Vaccine Safety & Efficacy

Vaccine efficacy refers to the ability of vaccines to bring about the intended beneficial effects on vaccinated individuals in a defined population under ideal conditions of use. The potential benefits of an effective vaccine – e.g. promotion of health and well-being, and protection from illness and its physical, psychological and socioeconomic consequences must be weighed against the potential risk of an adverse event following immunization (AEFI) with that vaccine. Vaccine-associated risk is the probability of an adverse or unwanted outcome occurring, and the severity of the resulting harm to the health of vaccinated individuals in a defined population following immunization with a vaccine under ideal conditions of use.

 


 


    Related Conference of Vaccine Safety & Efficacy

    April 15-16, 2021

    Tumor & Cancer Immunology and Pediatric-Oncology

    Toronto, Canada
    May 03-04, 2021

    International Online Conference on Immunology

    New York, USA
    May 06-06, 2021

    3rd International Conference on Dermatology and Allergic Diseases

    Singapore City, Singapore
    May 06-07, 2021

    9th World Summit on immunology & immunotherapy

    Prague, Czech Republic
    June 23-24, 2021

    34th World Congress on Vaccines and Immunization

    Osaka, Australia
    August 27-28, 2021

    5th International Conference on Emerging Infectious Diseases

    Amsterdam, Netherlands
    October 12-13, 2021

    International Conference on Vaccine and Vaccine research

    Manila, Philippines
    October 14-15, 2021

    13th Annual Conference on Cinical Immunology

    Cape Town, Australia
    October 14-15, 2021

    11th International Conference on Bacteriology and Infectious Diseases

    Cape Town, South Africa
    November 10-11, 2021

    International Conference on Immunology Research

    New York, USA

    Vaccine Safety & Efficacy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in